n-methyl-3,4-methylenedioxyamphetamine has been researched along with Hepatitis B in 1 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| White, B | 1 |
| Day, C | 1 |
| Degenhardt, L | 1 |
| Kinner, S | 1 |
| Fry, C | 1 |
| Bruno, R | 1 |
| Johnston, J | 1 |
1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Hepatitis B
| Article | Year |
|---|---|
Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
Topics: Adult; Amphetamine-Related Disorders; Australia; Comorbidity; Cross-Sectional Studies; Female; Hallu | 2006 |